Brisbane and Melbourne, Australia, 22 December 2008: Biotechnology companies Progen Pharmaceuticals Limited (ASX:PGL; NASDAQ:PGLA) and Avexa Limited (ASX: AVX) today announced the signing of an ...

Starting out in 1983 as a pioneer in antibody manufacturing, PROGEN has since become a globally operating biotech company that serves the life sciences and pharma sector. Building on our core ...

Biotechnology company Progen has been forced to dump its plans to merge with fellow life sciences company Avexa after a group of rebel shareholders scuttled the deal. A group of investors ...

Brisbane-based Progen Industries Ltd announced the sale of its Life Sciences business, allowing the biotech to focus on its core business of developing a cure for cancer. The Life Sciences ...

Its chief scientific officer, Dr. Laurence Marton, the former chair of the Department of Laboratory Medicine at the University of California, San Francisco, will take a job at Progen. The upfront ...